89 results
8-K
EX-3.2
SGTX
Sigilon Therapeutics Inc
11 Aug 23
Completion of Acquisition or Disposition of Assets
4:16pm
, by “Independent Counsel” (as hereinafter defined), or (ii) if no request is made by the claimant for a determination by Independent Counsel, (A) by the Board … Directors or the Disinterested Directors so direct, by Independent Counsel in a written opinion to the Board of Directors, a copy of which shall
SC 14D9/A
SGTX
Sigilon Therapeutics Inc
1 Aug 23
Tender offer solicitation (amended)
4:06pm
:
Lazard assumed and relied upon the accuracy and completeness of the foregoing information, without independent verification of such information. Lazard did … not conduct any independent valuation or appraisal of any of the assets or liabilities (contingent or otherwise) of Sigilon or concerning
SC 14D9
EX-99
SGTX
Sigilon Therapeutics Inc
13 Jul 23
Tender offer solicitation
8:18am
, by Independent Counsel in a written opinion to the Board, a copy of which shall be delivered to Indemnitee, or (4) if so directed by the Board … , by the stockholders of the Company.
(c) If the determination of entitlement to indemnification is to be made by Independent Counsel pursuant to Section 6(b
SC 14D9
6cx7p0
13 Jul 23
Tender offer solicitation
8:18am
SC TO-T
EX-99
h9nf3qwjw roxxn4
13 Jul 23
Third party tender offer statement
8:01am
SC TO-T
EX-99
rrh0 zgpf3kpp7q5
13 Jul 23
Third party tender offer statement
8:01am
8-K
EX-2.1
gp2nbkw4pl
29 Jun 23
Lilly to Acquire Sigilon Therapeutics
7:03am
8-K
qrqq6q8f0c d7cxjywh
22 May 23
Termination of a Material Definitive Agreement
4:37pm
DEFA14A
7vkjlahaxfzqo3is
6 Apr 23
Additional proxy soliciting materials
7:05am
8-K
EX-99.2
8p4 fgo6cxk8k
10 Nov 22
Sigilon Therapeutics Reports Third Quarter 2022 Financial Results and Business Highlights
7:37am
8-K
EX-99.1
jyg3xkpo ht7o5e10up
11 Oct 22
Regulation FD Disclosure
8:30am
8-K
fssz4
26 May 22
Submission of Matters to a Vote of Security Holders
12:00am
S-3
bidz gnnqtby444jqva
14 Apr 22
Shelf registration
4:34pm